Peptides in 2026: types, legal status, combinations and testing
Peptides range from FDA-approved drugs to research chemicals sold for laboratory use. This guide maps the 72 peptides and blends Prof. Peptide profiles by category, sets out the regulatory changes of 2026 in date order, and links each compound’s own page, where its evidence, clinic practice and side effects are reported with sources.
Start here: new to peptides? Peptides 101 covers what a peptide is, the evidence hierarchy, routes, reconstitution, storage and certificates of analysis.
What are peptides?
Peptides are short chains of amino acids, smaller than proteins, that the body uses as signals between cells. Some peptides are approved drugs with labels that set a dose, such as semaglutide, tirzepatide and tesamorelin. Many others have no approval anywhere and are sold as research chemicals labeled for laboratory use.
That split decides what can be said about each one. For an approved drug, the label and its trials report the dose and side effects. For an unapproved peptide, the record is usually small human studies, clinic-published protocols and animal work, and each Prof. Peptide profile reports those in that order. The glossary defines the terms used across the site.
Are peptides legal in 2026?
The legal status of a peptide in 2026 depends on whether it is an approved drug. Approved peptide drugs are prescribed and dispensed like other medicines. For unapproved peptides, the questions are whether pharmacies may compound them and whether research-grade vials may be sold, and both changed during 2026. The timeline below is in date order, each step from its source.
- FDA’s category list (content current as of April 22, 2026). FDA’s page of bulk substances that “may present significant safety risks” lists, among substances “previously in category 2 of the interim policies” whose nominations “were withdrawn by the nominators,” AOD-9604, BPC-157, CJC-1295, DSIP, epitalon, GHK-Cu (for injectable routes), LL-37, melanotan II, MOTS-c, PEG-MGF, selank, semax, TB-500 and thymosin alpha-1. The April 2026 update covers the change.
- FDA’s advisory committee, July 23–24, 2026. FDA staff’s briefing for the Pharmacy Compounding Advisory Committee concluded, for BPC-157, that “a balancing of the criteria weighs against” adding it to the 503A bulks list. The committee voted 8 to 6, with one abstention, in favor of adding BPC-157, ABC News reported that day, and voted to recommend adding BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, ABC News reported on July 24, with no tallies for the other five; FDA has posted no minutes or vote results. A committee vote is advisory and FDA decides.
- HHS enforcement-discretion notice, October 30, 2026. A notice in the Federal Register (91 FR 68526) sets a draft Enforcement Discretion Policy under which HHS “does not intend to take enforcement action against a State-licensed pharmacy, Federal facility, or licensed physician compounding a drug product using a peptide bulk drug substance found in Appendix A,” and states that it “is not binding on HHS or the public.” Which peptides Appendix A lists is in the report on the HHS policy.
- States. Louisiana’s Act 374 is covered in the Louisiana report; the federal announcements that preceded the HHS notice are in the peptide-ban report and its April update.
Category 2 is FDA’s list of substances that “may present significant safety risks” in compounding; it is not a ban on research-grade sales, and leaving it by withdrawal is not approval. Each profile’s “Is it legal?” section gives that compound’s own FDA, compounding and sport (WADA) status.
What are the main types of peptides?
Prof. Peptide groups peptides into 11 categories by what they are studied or used for, the same categories as the peptide library. Each category page lists its compounds and comparisons; the list below gives each group in a line.
- Metabolic & GLP-1 (16): GLP-1 receptor agonists and related compounds. This group holds FDA-approved drugs (semaglutide and tirzepatide) beside compounds that are approved nowhere, so each profile states which it is.
- Recovery & Tissue Repair (5): Peptides clinics use for tendon, ligament, muscle and gut recovery. BPC-157 has three small human pilots; most of the group's research is in animals.
- Performance & Energy (4): Growth-factor peptides (IGF-1 variants, MGF, follistatin) sold for muscle research. None is an approved drug in this form.
- Growth Hormone (12): Compounds that prompt the body's own growth hormone release: GHRH analogues (sermorelin, CJC-1295, tesamorelin) and ghrelin mimetics (ipamorelin, the GHRPs, MK-677). Tesamorelin is FDA-approved for a specific use.
- Cognitive & Nootropic (6)
- Skin Health & Anti-Aging (7)
- Gut Health & Immunity (5)
- Sleep & Recovery (1)
- Longevity (5)
- Bioregulators (7)
- Sexual Health (4)
Which peptides does Prof. Peptide profile?
Prof. Peptide profiles 72 peptides and blends. Each profile reports what the compound is, its uses as clinics report them, how clinics dose it, side effects, legal status, the human studies and a condensed animal and lab section, with every line attributed to its source.
5-Amino-1MQ · Adipotide · AOD-9604 · AOD-9604 + MOTS-c · Cagrilintide · CagriSema · HGH Fragment 176-191 · Mazdutide · Metabolic Blend (NAD+ / MOTS-c / 5-Amino-1MQ) · MOTS-c · Retatrutide · Semaglutide · Semaglutide + BPC-157 · Survodutide · Tirzepatide · Tirzepatide + BPC-157
CJC-1295 · CJC-1295 (No DAC) + Ipamorelin (GH Stack) · GHRP-2 · GHRP-6 · Hexarelin · Ipamorelin · MK-677 · MK-677 + Ipamorelin · Sermorelin · Sermorelin + Ipamorelin · Tesamorelin · Tesamorelin + Ipamorelin
AHK-Cu · GHK-Cu · GLOW · KLOW · Melanotan I (Afamelanotide) · Melanotan II · SNAP-8
Which peptides are used together?
Clinics most often combine peptides in a few recurring pairings: BPC-157 with TB-500, the same two with GHK-Cu or with GHK-Cu and KPV, and a GHRH analogue with ipamorelin. No trial has tested these combinations as combinations; each blend profile reports what clinics publish for it and the evidence for each component.
- Wolverine Stack (BPC-157 + TB-500); compared in BPC-157 vs TB-500
- GLOW and KLOW (adding GHK-Cu, and GHK-Cu with KPV)
- GH Stack, sermorelin + ipamorelin, tesamorelin + ipamorelin and MK-677 + ipamorelin
- KPV + BPC-157, semaglutide + BPC-157 and tirzepatide + BPC-157
- Semax + selank and PT-141 + oxytocin
How are research peptides tested?
Research peptides are tested by independent laboratories, which issue a certificate of analysis stating the identity, purity and measured content of the sample they received. A research-use-only label means the vial is sold for laboratory research, not for human use; it is neither an approved product nor a compounded prescription.
Peptide calculators
Prof. Peptide’s calculators do the arithmetic between a vial, a volume of diluent and the units on a syringe. They compute; they do not set a dose.
FAQ
What are peptides?
Are peptides legal in 2026?
What does research use only mean on a peptide vial?
Which peptides are most often combined?
References
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks (content current as of April 22, 2026); read November 4, 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- U.S. Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, July 23–24, 2026: BPC-157 related bulk drug substances; read November 4, 2026. https://www.fda.gov/media/193343/download
- U.S. Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, notice of availability, FR Doc. 2026-22192, 91 FR 68526 (October 30, 2026); text read November 4, 2026. https://www.federalregister.gov/documents/2026/10/30/2026-22192/enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances
- Salzman S, Kekatos M. ABC News, July 23, 2026 (read November 12, 2026): the BPC-157 vote, 8 to 6 with one abstention. https://abcnews.com/Health/fda-advisory-committee-votes-add-popular-peptide-bpc/story?id=134913891
- Daniel Y. ABC News, July 24, 2026 (read November 12, 2026): the committee voted to recommend BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax; no tallies. https://abcnews.com/Health/fda-advisers-narrowly-vote-add-6-peptides-drug/story?id=135064915
Affiliate disclosure: Prof. Peptide earns a commission on purchases and sign-ups made through its links and codes, at no extra cost to the buyer. Commissions never decide which vendors are listed, how they are ranked or verified, or what Prof. Peptide concludes.
Related pages
- Peptide Research Basics — A Practical PrimerWhat research peptides are, how they signal at receptors, why doses are measured in micrograms, and what third-party quality testing actually verifies.
- Insulin Syringe Units to mcg + How to Inject PeptidesHow to read insulin syringe units, convert units to mcg for any reconstitution, pick the right barrel size, and inject peptides subcutaneously step by step.
- Guides — Practical Peptide Research ReferencesPractical reference guides for peptide research — injection technique, reconstitution math, syringe sizing, and research fundamentals.
Checked and updated
